US FDA to re-evaluate silicone breast implants
This article was originally published in Clinica
Executive Summary
FDA lead deputy commissioner Michael Friedman last week told a House Commerce subcommittee on health that he will convene an internal group to re-evaluate what the agency's position should be on silicone breast implants in light of recent new data on the controversial devices.